Manus, an AI agent released by start-up Monica Photo: VCG Manus, an AI agent released by Singapore-based tech start-up Monica, said in a note to users on Tuesday that it will soon return to operating as an independent company. According to the company's note, "this is part of our separation from Meta; we must take this step to comply with regulatory requirements in specific parts of the world." As part of Manus transition back to independent operations and to comply with regulatory requirements in specific jurisdictions, data generated by certain users on or after December 29, 2025, will be deleted from 8:00 am on August 23 through August 24, 2026 (SGT), according to the note. Affected users will be able to back up their data from now until 7:59 am on August 23, 2026 (SGT) and restore it starting from 8:00 am on August 25, 2026 (SGT), according to the company. Regarding why the data deletion only affects data generated since December 29, 2025, Manus said in the note that Meta acquired Manus on that date. Data generated by some users on or after the acquisition needs to be deleted to comply with regulatory requirements in certain jurisdictions. In March 2025, the startup Butterfly Effect launched Manus. As the world's first general AI agent, Manus became an overnight sensation with a demo video, and access codes were, at one point, resold for tens of thousands of yuan. As a result, Manus was briefly seen by the industry as "the second DeepSeek." Just a few months later, however, Manus moved its headquarters to Singapore, significantly downsized its domestic team, retained only core technical staff, and ceased its services and operations in China. In December last year, Meta announced the acquisition of Manus for approximately $2 billion, making it the third-largest acquisition in Meta's history. In April, China's Office of the Working Mechanism for Security Review of Foreign Investment under the National Development and Reform Commission (NDRC) announced its decision to prohibit, in accordance with laws and regulations, the foreign acquisition of the Manus project and required the parties involved to revoke the transaction, according to the official website of the NDRC. This decision reflects China's continued efforts to improve its foreign investment review system and regulate cross-border mergers and acquisitions in accordance with laws and regulations, Ma Jihua, a veteran industry analyst, told the Global Times in a previous interview. Addressing a question that the office of the foreign investment security review working mechanism has formally issued a decision to prohibit foreign investment in the Manus acquisition project and has ordered the parties involved to revoke the acquisition deal, and that two Manus executives have reportedly been barred from leaving China, Lin Jian, a spokesperson for the Chinese Foreign Ministry, told a press briefing on April 28 that " As a matter of principle, I would like to stress that the Chinese government conducts reviews of foreign investment and makes relevant decisions in accordance with laws and regulations." Global Times 。 8月26日消息，中国首富钟睒睒再开启大额公益捐赠，此次捐赠资产价值高达9.27亿元。 8月25日盘后，北京万泰生物药业股份有限公司发布官方公告。公告显示，公司实际控制人钟睒睒，将其直接持有的3300万股万泰生物无限售流通股，无偿捐赠给福建省翔安创新实验室科技发展基金会，本次捐赠股份占公司总股本的2.61%。
本次捐赠完成后，钟睒睒个人直接持股比例从17.71%降至15.10%；其与控股股东养生堂的合计持股比例，由73.53%降至70.92%。 据悉，本次受赠方福建省翔安创新实验室科技发展基金会为慈善组织，于2025年11月27日正式成立。 根据公告约定，受赠方持有本次捐赠股份期间，所产生的全部收益（包含股息、红利及各类法定孳息等），以及后续减持该部分股份所得的税后资金，将专项用于公共健康与生物医学前沿领域的科研探索、人才培养、科技奖励及学术交流等公益事业。 公告同时明确，此次捐赠不会改变万泰生物的控股股东及实际控制人，对公司现有治理结构、日常经营及持续发展均不会产生重大影响。 此外，受赠方承诺，6个月内不会减持本次获赠股份，且未来进行股份减持时，将与钟睒睒合并计算减持额度，合规规范运作。
